Regenerative Medical Technology RMTG
OTC RMTG
$0.06 +0.00 (+0.00%)
At close: Sep 29, 2026 · 4:00 PM EDT

Regenerative Medical Technology (RMTG) Receivables - Other (2021 - 2022)

Updated

Regenerative Medical Technology (RMTG) recorded Receivables - Other of $86,262 in Q3 2022.

Analysis

Regenerative Medical Technology (RMTG) Receivables - Other (2021 - 2022) Analysis & Trends

At the end of FY2021, Regenerative Medical Technology reported Receivables - Other of $17,257.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Regenerative Medical Technology 824,338.06 -3.70 Mn 2.58 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 86,262.00
Dec 31, 2021 17,257.00
API Access

Regenerative Medical Technology Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=RMTG&period=max&api_key=YOUR_API_KEY